Skip to main navigation Skip to search Skip to main content

A Randomized, Phase 2, Double-Blind, Vehicle-Controlled Trial to Evaluate the Safety and Efficaccty of Q301 Cream in Patients with Moderate to Severe Atopic Dematitis

Project: Research

Project Details

StatusFinished
Effective start/end date05/26/15 → 05/25/17

Funding

  • Qurient Company Limited: $32,128.18